Lyme disease: uphill struggle.
Abbott
Alison
A
D000954:Antigens, Surface / Q000737:chemistry / Q000276:immunology; D001327:Autoimmune Diseases / Q000150:complications / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins / Q000737:chemistry / Q000276:immunology; D001428:Bacterial Vaccines; D025065:Borrelia burgdorferi / Q000737:chemistry / Q000276:immunology; D004345:Drug Industry; D005060:Europe; D006801:Humans; D008074:Lipoproteins / Q000737:chemistry / Q000276:immunology; D008193:Lyme Disease / Q000150:complications / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*; D022123:Lyme Disease Vaccines / Q000009:adverse effects* / Q000191:economics / Q000600:supply & distribution*; D008954:Models, Biological; D018716:Molecular Mimicry; D011639:Public Opinion; D015203:Reproducibility of Results; D014481:United States
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; D022123:Lyme Disease Vaccines; C072045:OspA protein